22
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Microencapsulation of the renin inhibitor FK906 by phase separation of ethylcellulose in cyclohexane

, , , &
Pages 335-346 | Received 10 Aug 1996, Accepted 20 Apr 1997, Published online: 27 Sep 2008

References

  • FK-906. Drugs of the future 1993; 18: 312–315, Anon.
  • Hashimoto N., Fujioka T., Hayashi K., Odaguchi K., Toyoda T., Nakamura M., Hirano K. Renin inhibitor: relation between molecular structure and oral absorption. Pharmaceutical Research 1994; 11: 1443–1447
  • Hjártstam J., Borg K., Linstedt. The effect of tensile stress on permeability of free films of ethyl cellulose containing hydroxypropyl methylcellulose. International Journal of Pharmaceutics 1990; 61: 101–107
  • Jang J.-W., Kitamura S., Guillory J. K. Some physicochemical properties of FK906; glass transition and relaxation. PDA Journal of Pharmaceutical Science and Technology 1995; 49: 42–49
  • John P. M., Minatoya H., Rosenberg F. J. Microencapsulation of biloterol for controlled release and its effect on bronchodilator and heart rate activities in dogs. Journal of Pharmaceutical Sciences 1979; 68: 475–480
  • Karajiannis H., van de Waterbeemd H. The prediction of the lipophilicity of peptidomimetics. A comparison between experimental and theoretical lipophilicity values of renin inhibitors and their building blocks. Pharmaceutica Acta Helvetiae 1995; 70: 67–77
  • Koida Y., Kobayashi M., Samejihia M. Studies on microcapcules. IV. Influence of properties of drugs on microencapsulation and dissolution behavior. Chemical and Pharmaceutical Bulletin 1986; 34: 3354–3361
  • Powell T. C. Wall sealing treatment for minute capsules and minute capsules having walls of sealed polymeric material. US Patent 3,623,997, 1971, The National Cash Register Company
  • Ragnarsson G., Sandberg A., Johansson M. O., Linsrem B., Sjögren J. In oitro release characteristics of a membrane-coated pellet formulation—influence of drug solubility and particle size. International Journal of Pharmaceutics 1992; 79: 223–232
  • Thohla K., Zimmer T. Retardation of weakly basic drugs. 1st communication: Improvement of availability-problems with noscapine in diffusion-pellets. Pharmazeutische Industrie 1989; 51: 98–101
  • Thoma K., Zimmer T. Retardation of weakly basic drugs. 2nd communication: optimization of availability with papaverine and codeine in diffusion-pellets. Pharmazeutische Industrie 1989; 51: 540–543
  • Thoma K., Knott F. Retardation of weakly basic drugs. 4th communication: solving the availability problems of vincamine from diffusion dosage forms. Pharmazeutische Industrie 1991; 53: 595–600

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.